Will Rosellini, JD, MBA
Chairman & Chief Executive Officer
Rosellini, a former minor-league pitcher, holds a law degree, MBA and 4 master's degrees (MS of Accounting, MS of Regulatory Science, MS of Bio-informatics, MS of Neuroscience). He has started 5 companies, done 3 acquisitions, raised $60M in financing and had 4 exits. He previously founded and led Lexington Technology Group, LLC, a database company commercializing a database solution with an exit to ("DSS" NYSE) Sarif Biomedical LLC, a stereotactic microsurgery company exit to ("MARA" NSDQ) and Telemend Medical, a clinical engineering services company exit to ("SPRV"OTC). He became a board member of Marathon Patent Group ("MARA") in 2013. Rosellini also founded Microtransponder in 2006 which is completing a pivotal study showing that vagus nerve stimulation coupled with rehab can alleviate deficits after a stroke. Will has been serving as the Chairman and CEO of Nexeon MedSystems since January 2016 which he took public in 2017.
Chief Financial Officer
Over the past 15 years, Chris Miller has served as CFO, treasurer and interim CFO for a wide variety of early-stage and non-profit organizations. Since 2002, Miller has been providing financial and business development consulting and interim CFO services, with a focus on early-stage companies. From 2006 to 2008, he provided public company valuation, financial modeling, and due diligence services to Doherty & Company, LLC, a Los Angeles based broker-dealer specializing in venture capital, private equity funding, mergers and acquisitions advisory and valuations for early-stage companies. He specializes in start-up financing, industry research, concept feasibility, business plan and investment memorandum development, private and public company valuations, audit management, due diligence, and corporate action plan execution.
Austin Duke, Ph.D.
Chief Science Officer
Dr. Duke is a scientist, engineer, and medical device entrepreneur specializing in the translation of early-stage ideas to viable products. His efforts primarily encompass R&D, clinical, and regulatory activities for all of Nexeon's product pipelines. Prior to Nexeon, Dr. Duke served as the VP of Emerging Therapies at Rosellini Scientific, where he led non-dilutive funding initiatives and preclinical/clinical development of pipeline projects. Dr. Duke is a patented inventor and his work was highlighted in Nature Photonics and selected as a Highlight of 2012 by Journal of Neural Engineering. Dr. Duke obtained his MS and Ph.D. in Biomedical Engineering from Vanderbilt University, where he developed novel methods of peripheral neurostimulation. Prior to Vanderbilt, he graduated Magna Cum Laude from North Carolina State University with a BS in Biomedical Engineering concentrating on biomedical instrumentation.
Luc Van Immerseel, Ph.D.
Senior R&D and Neurophysiology Expert
Dr. Van Immerseel is a senior R&D and neurophysiology expert with over 20 years of experience in hearing, cochlear implants (CI) and Neuromodulation devices. He designed a new CI stimulation ASIC and multiple stimulation paradigms for Antwerp Bionic Systems, Philips Hearing Implants and Advanced Bionics Corporation. For several years he did research and development on the recording of evoked potentials with a combination of modeling, in vivo recording in animals and studies with CI patients. Thereafter, he developed software platforms for research in stimulation and recording for Advanced Bionics Corporation. After moving to 3WIN N.V. he co-designed the ASIC (PICS) that is the stimulation core of the Viant implant and took the lead in the development and CE approval of all embedded and PC software in the Synapse system. Once CE approval was obtained he designed and developed applications for advanced DBS clinical research focusing on the combination of neural recording (local field and evoked potentials) and stimulation patterns for more efficient therapy with less side effects.
Cathal Mc Fadden
Vice President Operations
Mr. Mc Fadden is a medical device professional with more than 12 years of experience within the medical device industry. He currently serves as Vice President Operations at Nexeon having previously been the Director of Manufacturing. His main duties involve day to day running of business operations which include responsibility for the design transfer and up-scaling of Nexeon's product portfolio, collaborating with some of the industry's best-known suppliers and contract manufacturers. In 2017 he was directly responsible for the successful provision of the associated deliverables as part of a supply agreement with Galvani Bioelectronics (a joint partnership between Google and GSK) which included implantable devices for the investigation of the latest Neuromodulation indications. Mr. Mc Fadden previously worked with Synaptix N.V. a Belgian manufacturer of Neuromodulation platforms. During his at time at Synaptix he was a key team member in the European Approval of an implantable DBS platform (Synapse) for the alleviation of Parkinson's disease and movement disorders in 2012. Prior to then he served as Head of Engineering with Wiss Medi Teo (Ireland), a contract manufacturer of medical devices for companies such as Hospira Inc. (now ICU Medical Inc.) and Abbott Laboratories. Mr. Mc Fadden graduated with distinction from the Dublin Institute of Technology (DIT) Ireland, with a Bachelor of Engineering Technology in Mechanical Engineering specializing in manufacturing.
Stephane Béfahy, Ph.D.
Vice President Quality Affairs
Dr. Béfahy has more than 12 years of experience in the development of Active Implantable Medical Devices (AIMD) including Vagus Nerve Stimulator (VNS) for treating epilepsy and heart failure, Deep Brain Stimulator (DBS) for Parkinson's disease, and Hypoglossal Nerve Stimulator (HGNS) for Obstructive Sleep Apnea (OSA). He previously served as project leader in SME at Neurotech SA as well as at the larger company Sorin Group/ LivaNova. Through his diverse experience, he has acquired wide multi-disciplinary skills in R&D, intellectual property development and management, manufacturing, operations, QA/RA, clinical trials, and market access. He has a proven track record of establishing and executing development plans for innovative solutions with a rapid time to market cycle
Ryan Sefkow, MS
Product Development Leader and Mechanical Engineer
Mr. Sefkow is a product development leader and mechanical engineer with more than 10 years of experience bringing medical devices to market. Prior to joining Nexeon, he was with Abbott Laboratories (formerly St. Jude Medical) in their Neuromodulation division holding numerous roles within their Neuro Leads Development group including Principal Mechanical Engineer, Manager of Mechanical Engineering, and Director of Mechanical Engineering. Prior to working in the Neuromodulation division, Mr. Sefkow worked in St. Jude Medical's Cardiac division as a Senior Product Development Engineer in their CRT delivery. Prior to St. Jude Medical, Mr. Sefkow worked at Lake Region Medical in their New Product Introduction group as a Senior Product/Process Development Design Engineer where he led teams in developing the processes to manufacture both Lake Region Medical's internal products and external customer's products. These products included guidewires, implantable components, and implantable assemblies. Prior to the medical device industry, Mr. Sefkow worked at Hutchinson Technology as a Product Design Engineer and Advanced Process Development Engineer where he designed read/write head suspensions in hard drives and the processes to produce them. Mr. Sefkow obtained his BS and MS in Mechanical Engineering from the University of Minnesota and currently holds 4 patents.